Key result
Higher Systemic Immune-Inflammation Index (SII) was associated with the presence of metabolic syndrome in obese children and adolescents, demonstrating better discriminative ability than SIRI.
Why the study?
With rising pediatric obesity and metabolic syndrome worldwide, early identification of children with obesity who are prone to developing metabolic syndrome is important.
Do the Systemic Immune-Inflammation Index (SII) and Systemic Inflammatory Response Index (SIRI) predict the presence of metabolic syndrome in obese children and adolescents?
Cross-Sectional (n=99)
No
Do the Systemic Immune-Inflammation Index (SII) and Systemic Inflammatory Response Index (SIRI) predict the presence of metabolic syndrome in obese children and adolescents?
The Systemic Immune-Inflammation Index (SII) and Systemic Inflammatory Response Index (SIRI) derived from routine blood counts can serve as accessible biomarkers for the early identification of metabolic syndrome in obese children and adolescents.
Answers are grounded in this paper and cite their sources.
SII/SIRI may aid MetS risk stratification in obese youth; hypothesis-generating and requires prospective validation before clinical use.
Background: With the increase in pediatric obesity, the prevalence of metabolic syndrome (MetS) is rising worldwide. Early identification of children with obesity who are prone to developing MetS is important. Objectives: This study aimed to evaluate the value of the Systemic Immune–Inflammation Index (SII) and the Systemic Inflammatory Response Index (SIRI) in predicting MetS in obese children and adolescents. Methods: This prospective single-center cross-sectional study involved 99 children and adolescents with obesity. The patients were assigned to two groups, MetS+ (n = 42) and MetS- (n = 57), based on the presence of MetS. Complete blood count results from the first visit were evaluated. Results: The white blood cell (WBC), platelet, and neutrophil counts were higher in the MetS+ group (P = 0.003, P = 0.022, and P < 0.001, respectively), while no significant difference was observed in lymphocyte (P = 0.865) and monocyte counts (P = 0.488) between the two groups. When inflammatory parameters were compared, SII (P < 0.001), platelet-to-lymphocyte ratio (PLR) (P = 0.024), neutrophil-to-lymphocyte ratio (NLR) (P = 0.002), and SIRI (P = 0.012) were significantly elevated in the MetS+ group compared to the MetS- group. Binary logistic regression analysis revealed that SII and homeostasis model assessment of insulin resistance (HOMA-IR) were statistically significant risk factors for the presence of MetS (P = 0.003, P = 0.012, respectively). Additionally, a significant positive correlation was found between SII and diastolic blood pressure (DBP) (P = 0.024), high-density lipoprotein cholesterol (HDL-C) (P = 0.019), and fasting plasma glucose (FPG) (P = 0.048), as well as between SIRI and HDL-C (P = 0.044) and FPG (P < 0.001). Receiver operating characteristic analysis of the SII and SIRI ability to predict MetS in adolescents and children with obesity showed that the SII was more discriminative than the SIRI, with a specificity of 0.82, sensitivity of 0.57, and an area under the curve of 0.708. Conclusions: The SII and SIRI can be used for the early diagnosis of MetS in pediatric obesity patients.
No takes yet. Share an insight, caveat, or question.
Gayret et al. (2024) conducted a cross-sectional in Obesity and Metabolic Syndrome (n=99). Systemic Immune-Inflammation Index (SII) vs. Lower SII values was evaluated on Presence of Metabolic Syndrome (MetS) (OR 1.005, 95% CI 1.002-1.008, p=0.003). Higher Systemic Immune-Inflammation Index (SII) was associated with the presence of metabolic syndrome in obese children and adolescents, demonstrating better discriminative ability than SIRI.
Synapse has enriched 10 related papers. Consider them for comparative context: